Novo Nordisk (NYSE: NVO) 30-day option implied volatility is at 26; compared to its 52-week range of 22 to 44. Call put ratio 2.1 calls to 1 put with focus on September 175 calls after Biden demands Novo Nordisk, Lilly lower GLP-1 drug prices in USAToday editorial into 2024 elections.